Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
Y - Young Investigator & First Time Attendee Session
- Type: Other Sessions
- Track: Other Topics
- Presentations: 8
- Moderators:M. Edelman
- Coordinates: 10/27/2013, 08:00 - 11:30, Parkside Ballroom A+B, Level 1
-
+
Y.2 - How to Present Data at a Conference
08:20 - 08:40 | Author(s): M. Boyer
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL01 - Opening Plenary
- Type: Plenary Session
- Track: Prevention & Epidemiology
- Presentations: 2
- Moderators:M. Boyer
- Coordinates: 10/27/2013, 18:45 - 20:15, Plenary Hall, Ground Level
-
+
PL03 - Presidential Symposium Including Top Rated Abstracts
- Type: Plenary Session
- Track:
- Presentations: 8
- Moderators:M. Boyer
- Coordinates: 10/29/2013, 08:15 - 09:45, Plenary Hall, Ground Level
-
+
PL03.01 - Lung cancer probability in subjects with CT-detected pulmonary nodules
08:15 - 08:27 | Author(s): N. Horeweg
- Abstract
Loading... -
+
PL03.02 - DISCUSSANT
08:27 - 08:37 | Author(s): C. Berg
- Abstract
No abstract available for this presentation
-
+
PL03.03 - MesoVATS: A multi-centre randomised controlled trial of video assisted thoracoscopic pleurectomy versus talc pleurodesis in malignant pleural mesothelioma
08:37 - 08:49 | Author(s): R.C. Rintoul
- Abstract
Loading... -
+
PL03.04 - DISCUSSANT
08:49 - 08:59 | Author(s): V. Rusch
- Abstract
No abstract available for this presentation
-
+
PL03.05 - An intergroup randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) chemoradiotherapy (CRT) +/- cetuximab (cetux) for stage III non-small cell lung cancer (NSCLC): Results on cetux from RTOG 0617
08:59 - 09:11 | Author(s): J. Bradley
- Abstract
Loading... -
+
PL03.06 - DISCUSSANT
09:11 - 09:21 | Author(s): J. Jassem
- Abstract
No abstract available for this presentation
-
+
PL03.07 - Treatment with Therapies Matched to Oncogenic Drivers Improves Survival in Patients with Lung Cancers: Results from The Lung Cancer Mutation Consortium (LCMC)
09:21 - 09:33 | Author(s): M.G. Kris
- Abstract
Loading... -
+
PL03.08 - DISCUSSANT
09:33 - 09:43 | Author(s): B. Solomon
- Abstract
No abstract available for this presentation
-
+
P2.06 - Poster Session 2 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 50
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.06-011 - Phosphorylated-Akt expression is a prognostic marker in early stage non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): P.Y. Yip
- Abstract
Loading...
-
+
P2.10 - Poster Session 2 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.10-040 - Prognostic significance, accuracy and usefulness of oncologists' estimates of survival time for patients starting first-line chemotherapy for advanced non-small-cell lung cancer (ANSCLC)
09:30 - 09:30 | Author(s): B.E. Kiely
- Abstract
Loading...
-
+
P2.11 - Poster Session 2 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 46
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.11-032 - Patient Report of Dacomitinib (PF-00299804)-Associated Symptom and HRQoL Benefit in Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): J.P. Doherty
- Abstract
Loading...
-
+
P3.14 - Poster Session 3 - Mesothelioma
- Type: Poster Session
- Track: Mesothelioma
- Presentations: 14
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.14-004 - Adjuvant Hemithoracic Radiotherapy After Extrapleural Pneumonectomy For Malignant Pleural Mesothelioma: Experience At The Sydney Cancer Centre
09:30 - 09:30 | Author(s): A. Bece
- Abstract
Loading... -
+
P3.14-012 - Pathological complete response after platinum-based chemotherapy in malignant pleural mesothelioma
09:30 - 09:30 | Author(s): S.S. Kumar
- Abstract
Loading...
